TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 3 | -2 | -6 | -13 | -27 | -18 | -10 |
| S | %wins | 0 | 100 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/18 17:08 | 3/15/18 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Germain Mark | NY | D | S.m | -68 | 1.48 | 0 | -46 | -8 | 514 | D | |||||||||||||||
3/15/18 17:12 | 3/14/18 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Germain Mark | NY | D | S | -36 | 1.50 | 0 | -24 | -4 | 560 | D | |||||||||||||||
6/19/14 16:06 | 6/18/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Germain Mark | NY | D | S | -135 | 3.12 | 0 | -43 | -13 | 291 | D | 35 | 14 | -3 | -20 | -9 | -8 | -3 | -2 | 1 | -2 | -7 | -7 | -23 | -15 | |
3/5/14 16:19 | 3/4/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Germain Mark | NY | D | S | -273 | 4.02 | 1 | -68 | -17 | 334 | D | 82 | 27 | 37 | 24 | -2 | -2 | 1 | -1 | 4 | -1 | -4 | -19 | -30 | -20 | |
12/3/03 10:19 | 12/1/03 | WRP | Wellsford Real Properties Inc | MD | RlEst | REIT | Real Estate Investment Trusts | Germain Mark | NY | D | S | -48 | 17.99 | 0 | -3 | -57 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |